CytomX

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. 

CEO
Sean A. McCarthy
CEOSean A. McCarthy
Employees
121
Employees121
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2010
Founded2010
Employees
121
Employees121

CTMX Key Statistics

Market cap
311.15M
Market cap311.15M
Price-Earnings ratio
4.03
Price-Earnings ratio4.03
Dividend yield
Dividend yield
Average volume
18.77M
Average volume18.77M
High today
$2.11
High today$2.11
Low today
$1.95
Low today$1.95
Open price
$2.06
Open price$2.06
Volume
907.23K
Volume907.23K
52 Week high
$2.55
52 Week high$2.55
52 Week low
$0.40
52 Week low$0.40

CTMX News

Simply Wall St 4h
CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

CytomX Therapeutics, Inc. ( ) just released its quarterly report and things are looking bullish. Statutory earnings performance was extremely strong, with reven...

CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Benzinga 1d
This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
TipRanks 2d
Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Confident Invest...

More CTMX News

TipRanks 3d
CytomX Therapeutics Secures $93.4 Million Through Stock Sale

Protect Your Portfolio Against Market Uncertainty CytomX Therapeutics ( (CTMX) ) just unveiled an update. On May 12, 2025, CytomX Therapeutics entered into an...

TipRanks 4d
CytomX Therapeutics Reports Positive Interim Phase 1 Data

CytomX Therapeutics ( (CTMX) ) has shared an update. On May 12, 2025, CytomX Therapeutics announced positive interim Phase 1 data for its EpCAM PROBODY® ADC ca...

People also own

Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.